NASDAQ:HCAT Health Catalyst (HCAT) Stock Forecast, Price & News $10.12 +0.46 (+4.76%) (As of 09/29/2023 ET) Add Compare Share Share Today's Range$9.66▼$10.1450-Day Range$9.35▼$14.3252-Week Range$6.40▼$15.87Volume916,574 shsAverage Volume369,554 shsMarket Capitalization$576.44 millionP/E RatioN/ADividend YieldN/APrice Target$14.55 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability Health Catalyst MarketRank™ ForecastAnalyst RatingModerate Buy2.56 Rating ScoreUpside/Downside43.7% Upside$14.55 Price TargetShort InterestHealthy1.79% of Shares Sold ShortDividend StrengthN/ASustainability-0.91Upright™ Environmental ScoreNews Sentiment0.78Based on 5 Articles This WeekInsider TradingSelling Shares$73,600 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($0.93) to ($0.85) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.40 out of 5 starsMedical Sector203rd out of 972 stocksComputer Programming, Data Processing, & Other Computer Related Industry19th out of 61 stocks 3.3 Analyst's Opinion Consensus RatingHealth Catalyst has received a consensus rating of Moderate Buy. The company's average rating score is 2.56, and is based on 5 buy ratings, 4 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $14.55, Health Catalyst has a forecasted upside of 43.7% from its current price of $10.12.Amount of Analyst CoverageHealth Catalyst has only been the subject of 2 research reports in the past 90 days. Previous Next 4.0 Short Interest Percentage of Shares Shorted1.79% of the outstanding shares of Health Catalyst have been sold short.Short Interest Ratio / Days to CoverHealth Catalyst has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Health Catalyst has recently decreased by 1.92%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldHealth Catalyst does not currently pay a dividend.Dividend GrowthHealth Catalyst does not have a long track record of dividend growth. Previous Next 3.8 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreHealth Catalyst has received a 48.83% net impact score from Upright. Health Catalyst seems to create the most significant positive value in categories "Taxes", "Creating knowledge", and "Physical diseases". The positive contribution in the "Creating knowledge" impact category is mostly driven by its "Health data collection software", "Data analytics services", and "Drug discovery software" products. See details.Environmental SustainabilityThe Environmental Impact score for Health Catalyst is -0.91. Previous Next 2.7 News and Social Media Coverage News SentimentHealth Catalyst has a news sentiment score of 0.78. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Health Catalyst this week, compared to 2 articles on an average week.MarketBeat Follows2 people have added Health Catalyst to their MarketBeat watchlist in the last 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Health Catalyst insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $73,600.00 in company stock.Percentage Held by InsidersOnly 2.70% of the stock of Health Catalyst is held by insiders.Percentage Held by Institutions86.63% of the stock of Health Catalyst is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Health Catalyst are expected to grow in the coming year, from ($0.93) to ($0.85) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Health Catalyst is -3.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Health Catalyst is -3.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHealth Catalyst has a P/B Ratio of 1.30. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Health Catalyst (NASDAQ:HCAT) StockHealth Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company offers data operating system data platform for analytics, and application development and interoperability that provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications designed to analyze the problems faced across clinical and quality, population health, and financial and operational use cases. It also provides services expertise, which include data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.Read More HCAT Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HCAT Stock News HeadlinesSeptember 29, 2023 | americanbankingnews.comHead to Head Contrast: Clikia (OTCMKTS:CLKA) versus Health Catalyst (NASDAQ:HCAT)September 27, 2023 | finance.yahoo.comHealth Catalyst Pop Analyzer™ and Health Catalyst Care Flow™ Achieve NCQA Population Health Management Prevalidation StatusOctober 1, 2023 | Behind the Markets (Ad)66,000% upside on tiny biotech?The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.September 27, 2023 | americanbankingnews.comHealth Catalyst, Inc. (NASDAQ:HCAT) Given Average Recommendation of "Moderate Buy" by AnalystsSeptember 15, 2023 | nasdaq.comCantor Fitzgerald Reiterates Health Catalyst (HCAT) Overweight RecommendationSeptember 5, 2023 | finance.yahoo.comHealth Catalyst Recognized in Five Gartner® Hype Cycle™ ReportsAugust 29, 2023 | msn.comCanaccord Genuity Maintains Health Catalyst (HCAT) Buy RecommendationAugust 15, 2023 | finance.yahoo.comSteven Cohen's Q2 2023 13F Filing Update: Top Trades and Portfolio OverviewOctober 1, 2023 | Behind the Markets (Ad)66,000% upside on tiny biotech?The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.August 10, 2023 | finance.yahoo.comHere’s Why Conestoga Micro Cap Strategy Sold Health Catalyst (HCAT)August 9, 2023 | finanznachrichten.deHealth Catalyst, Inc.: Health Catalyst Reports Second Quarter 2023 ResultsAugust 9, 2023 | finance.yahoo.comHealth Catalyst (HCAT) Reports Q2 Earnings: What Key Metrics Have to SayAugust 8, 2023 | theglobeandmail.comHealth Catalyst's (NASDAQ:HCAT) Q2 Earnings Results: Revenue In Line With Expectations But Quarterly Guidance UnderwhelmsAugust 8, 2023 | finance.yahoo.comHealth Catalyst Reports Second Quarter 2023 ResultsAugust 8, 2023 | finance.yahoo.comHealth Catalyst Is Great Place To Work® Certified™ in IndiaAugust 8, 2023 | finance.yahoo.comHealth Catalyst (HCAT) Q2 Earnings and Revenues Surpass EstimatesJuly 30, 2023 | finance.yahoo.comHealth Catalyst (NASDAQ:HCAT) shareholders have endured a 61% loss from investing in the stock three years agoJuly 28, 2023 | finance.yahoo.comSteven Cohen Boosts Stake in Health Catalyst IncJuly 28, 2023 | finance.yahoo.comTwistle by Health Catalyst Achieves HITRUST CSF® CertificationJuly 21, 2023 | markets.businessinsider.comRBC Capital Sticks to Its Hold Rating for Health Catalyst (HCAT)July 12, 2023 | finanznachrichten.deFinancialnewsmedia.com: Growing Number of Industries Realize the Urgency for Ransomware ProtectionJuly 10, 2023 | markets.businessinsider.comHealth Catalyst (HCAT) Gets a Buy from Wells FargoJune 28, 2023 | msn.comHealth Catalyst: Share Price Still Not Reflective Of Intrinsic ValueJune 27, 2023 | finance.yahoo.comOhio Health Information Partnership Powers CliniSync with Health CatalystJune 21, 2023 | seekingalpha.comHealth Catalyst: Recovery Won't Be SoonMay 15, 2023 | finance.yahoo.comCEO & Director of Health Catalyst Picks Up 6.9% More Stock \May 12, 2023 | msn.comGuggenheim Downgrades Health Catalyst (HCAT)See More Headlines Receive HCAT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Health Catalyst and its competitors with MarketBeat's FREE daily newsletter. Email Address HCAT Company Calendar Last Earnings8/08/2023Today10/01/2023Next Earnings (Estimated)11/14/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Computer programming, data processing, & other computer related Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:HCAT CUSIPN/A CIK1636422 Webwww.healthcatalyst.com Phone(801) 708-6800FaxN/AEmployees1,200Year FoundedN/APrice Target and Rating Average Stock Price Forecast$14.55 High Stock Price Forecast$18.00 Low Stock Price Forecast$8.00 Forecasted Upside/Downside+43.7%Consensus RatingModerate Buy Rating Score (0-4)2.56 Research Coverage9 Analysts Profitability EPS (Most Recent Fiscal Year)($2.68) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-137,400,000.00 Net Margins-51.76% Pretax Margin-51.63% Return on Equity-16.49% Return on Assets-9.11% Debt Debt-to-Equity Ratio0.58 Current Ratio4.74 Quick Ratio4.74 Sales & Book Value Annual Sales$276.24 million Price / Sales2.09 Cash FlowN/A Price / Cash FlowN/A Book Value$7.76 per share Price / Book1.30Miscellaneous Outstanding Shares56,960,000Free Float55,425,000Market Cap$576.44 million OptionableNot Optionable Beta1.30 10 Best Stocks to Own in 2023Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2023 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Daniel D. Burton (Age 48)CEO & Director Comp: $158.9kMr. Bryan Truman Hunt (Age 36)Chief Financial Officer Comp: $370.46kMr. Daniel H. Orenstein (Age 53)Sr. Advisor Comp: $356.56kMr. Kevin Freeman (Age 50)Chief Commercial Officer Comp: $405.9kMs. Anne Marie Bickmore (Age 60)COO & Chief Product Officer Mr. Jason Alger (Age 39)Chief Accounting Officer Mr. Dave RossChief Technology OfficerMr. Adam BrownSr. VP of Investor Relations and Financial Planning & AnalysisMr. Benjamin LandryGen. Counsel & Sec. of the BoardMs. Tarah Neujahr BryanChief Marketing & Communications OfficerMore ExecutivesKey CompetitorsOlema PharmaceuticalsNASDAQ:OLMAHilleVaxNASDAQ:HLVXAlectorNASDAQ:ALECTarsus PharmaceuticalsNASDAQ:TARSPhibro Animal HealthNASDAQ:PAHCView All CompetitorsInsiders & InstitutionsLinda LlewelynSold 1,160 sharesTotal: $12,771.60 ($11.01/share)Jason AlgerSold 2,197 sharesTotal: $25,595.05 ($11.65/share)Benjamin LandrySold 1,157 sharesTotal: $13,328.64 ($11.52/share)Linda LlewelynSold 737 sharesTotal: $8,770.30 ($11.90/share)Virginia Retirement Systems ET ALBought 36,500 shares on 8/22/2023Ownership: 0.064%View All Insider TransactionsView All Institutional Transactions HCAT Stock - Frequently Asked Questions Should I buy or sell Health Catalyst stock right now? 9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Health Catalyst in the last year. There are currently 4 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" HCAT shares. View HCAT analyst ratings or view top-rated stocks. What is Health Catalyst's stock price forecast for 2023? 9 equities research analysts have issued 1 year target prices for Health Catalyst's stock. Their HCAT share price forecasts range from $8.00 to $18.00. On average, they expect the company's share price to reach $14.55 in the next twelve months. This suggests a possible upside of 43.7% from the stock's current price. View analysts price targets for HCAT or view top-rated stocks among Wall Street analysts. How have HCAT shares performed in 2023? Health Catalyst's stock was trading at $10.63 at the start of the year. Since then, HCAT stock has decreased by 4.8% and is now trading at $10.12. View the best growth stocks for 2023 here. When is Health Catalyst's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023. View our HCAT earnings forecast. How were Health Catalyst's earnings last quarter? Health Catalyst, Inc. (NASDAQ:HCAT) announced its earnings results on Tuesday, August, 8th. The company reported ($0.21) earnings per share for the quarter, beating the consensus estimate of ($0.30) by $0.09. The firm earned $73.21 million during the quarter, compared to analysts' expectations of $72.67 million. Health Catalyst had a negative trailing twelve-month return on equity of 16.49% and a negative net margin of 51.76%. What ETFs hold Health Catalyst's stock? ETFs with the largest weight of Health Catalyst (NASDAQ:HCAT) stock in their portfolio include Fidelity Digital Health ETF (FDHT), ROBO Global Healthcare Technology and Innovation ETF (HTEC), SPDR FactSet Innovative Technology ETF (XITK) and First Trust Nasdaq Lux Digital Health Solutions ETF (EKG).iShares U.S. Healthcare Providers ETF (IHF). What guidance has Health Catalyst issued on next quarter's earnings? Health Catalyst updated its third quarter 2023 earnings guidance on Tuesday, August, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $70.20 million-$74.20 million, compared to the consensus revenue estimate of $72.86 million. What is Dan Burton's approval rating as Health Catalyst's CEO? 501 employees have rated Health Catalyst Chief Executive Officer Dan Burton on Glassdoor.com. Dan Burton has an approval rating of 99% among the company's employees. This puts Dan Burton in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 83.0% of employees surveyed would recommend working at Health Catalyst to a friend. What other stocks do shareholders of Health Catalyst own? Based on aggregate information from My MarketBeat watchlists, some companies that other Health Catalyst investors own include NVIDIA (NVDA), Salesforce (CRM), Alteryx (AYX), Walt Disney (DIS), DocuSign (DOCU), Block (SQ), Slack Technologies (WORK), ServiceNow (NOW), Marvell Technology (MRVL) and PayPal (PYPL). When did Health Catalyst IPO? (HCAT) raised $129 million in an IPO on Thursday, July 25th 2019. The company issued 6,000,000 shares at a price of $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and William Blair served as the underwriters for the IPO and Piper Jaffray, Evercore ISI, SVB Leerink and SunTrust Robinson Humphrey were co-managers. What is Health Catalyst's stock symbol? Health Catalyst trades on the NASDAQ under the ticker symbol "HCAT." How do I buy shares of Health Catalyst? Shares of HCAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Health Catalyst's stock price today? One share of HCAT stock can currently be purchased for approximately $10.12. How much money does Health Catalyst make? Health Catalyst (NASDAQ:HCAT) has a market capitalization of $576.44 million and generates $276.24 million in revenue each year. The company earns $-137,400,000.00 in net income (profit) each year or ($2.68) on an earnings per share basis. How many employees does Health Catalyst have? The company employs 1,200 workers across the globe. How can I contact Health Catalyst? Health Catalyst's mailing address is 3165 MILLROCK DRIVE SUITE 400, SALT LAKE CITY UT, 84121. The official website for the company is www.healthcatalyst.com. The company can be reached via phone at (801) 708-6800 or via email at ir@healthcatalyst.com. This page (NASDAQ:HCAT) was last updated on 10/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Health Catalyst, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.